What’s New in Photon Counting CT?

October 23, 2026 · 8 articles · 7 research themes · covering October 16, 2026 – October 23, 2026

Overview

Across this week’s articles, a clear theme is the move from “does disease exist?” toward more quantitative, phenotype-aware imaging that can guide management. In coronary disease, photon-counting CT (PCCT) is highlighted as a way to reveal high-risk plaque biology (e.g., lipid-rich phenotype) even when conventional clinical biomarkers are low, and broader reviews emphasize cardiac CT’s expanding role in first-line evaluation and comprehensive risk stratification for stable chest pain.

Methodological rigor and protocol standardization also recur. Studies optimize PCCT acquisition strategies for coronary CTA—balancing spatial/temporal performance and radiation dose—while other work focuses on practical workflow elements (nurse-led gastric preparation) to improve PCCT-based virtual endoscopy-like visualization. In parallel, the chronic subdural hematoma state-of-practice statement underscores that imaging phenotypes are promising but not yet standardized or validated for trial integration, calling for harmonized definitions to enable evidence-based treatment selection.

Finally, the digest shows PCCT and related CT technologies extending into functional and predictive domains beyond cardiology. PCCT-derived iodine metrics are explored as potential surrogates for treatment response in rectal adenocarcinoma by benchmarking against MRI diffusion (ADC). Meanwhile, detector technology and contrast timing influence carotid body detectability on PCCT, and a separate narrative review proposes a structured evidence framework to implement low-iodine dual-energy CT pulmonary angiography for pulmonary embolism without sacrificing diagnostic reliability.

---

Photon-Counting CT (PCCT) for Coronary Plaque & Risk Stratification

PCCT and IVUS-NIRS for High-Risk Plaque Management.

This case report studied advanced coronary imaging in a 59-year-old woman with acute chest pain, mild ischemic ECG changes, and negative high-sensitivity troponin but atypical/low-risk presentation. Photon-counting CT (PCCT) identified a predominantly noncalcified, lipid-rich-appearing left anterior descending plaque, and intravascular ultrasound with near-infrared spectroscopy (IVUS-NIRS) confirmed a high-risk lipid plaque phenotype despite low clinical biomarkers. The report highlights how PCCT plus IVUS-NIRS can uncover high-risk coronary plaque biology that may be missed by standard biomarkers and risk stratification, potentially informing escalation of management.

Nguyen CD, Pham DC, Quynh Tran HT et al. · JACC. Case reports · (2026) · View on PubMed ↗

The evolving role of cardiac CT: Emerging technologies and clinical impact.

This review studied the evolving clinical role of cardiac computed tomography (CT), including coronary CT angiography (CCTA) and broader applications across coronary, myocardial, valvular, and structural heart disease. It reports that CCTA is increasingly endorsed as a first-line test in appropriately selected patients with stable chest pain or suspected chronic coronary syndromes, enabling exclusion of obstructive disease, assessment of atherosclerotic burden, and guidance for preventive therapy and referral for invasive angiography. The review’s significance is to contextualize emerging cardiac CT technologies as a shift from purely diagnostic exclusion toward comprehensive risk stratification and management planning.

Oda S, Iima M, Yanagawa M et al. · Diagnostic and interventional imaging · (2026) · View on PubMed ↗ · Free PDF ↗

---

PCCT Acquisition Protocol Optimization (Coronary CTA)

Impact of Photon-Counting CT Acquisition Modes on Coronary Stenosis Assessment and Radiation Dose: A Phantom and Clinical Evaluation.

This phantom and clinical evaluation studied how photon-counting CT acquisition modes affect coronary stenosis assessment and radiation dose using first-generation dual-source photon-counting detector CT. Four acquisition modes (high-pitch spiral with prospective ECG-gating “Flash,” Sequence, Spiral, and retrospective ultra-high-resolution [UHR] spiral) were compared for image quality, blooming, stenosis grading, diagnostic accuracy, and dose. The results are significant for optimizing PCCT protocol selection to balance spatial resolution, temporal robustness, and patient radiation exposure in coronary CT angiography.

Stein T, Lang F, Bamberg F et al. · Zeitschrift fur medizinische Physik · (2026) · View on PubMed ↗ · Free PDF ↗

---

Photon-Counting CT (PCCT) for Gastric Virtual Endoscopy Imaging

Nurse-Led Gastric Preparation for Gas-Negative-Contrast Volume-Rendered Three-Dimensional Virtual Endoscopy-Like Gastric Imaging on Photon-Counting CT: A Prospective Randomized Clinical Study.

This prospective randomized clinical trial studied nurse-led gastric preparation strategies for photon-counting CT (PCCT)-based gas-negative-contrast volume-rendered (gas-VRT) virtual endoscopy-like gastric imaging in 120 patients undergoing contrast-enhanced abdominal CT. Compared across four arms (PCCT-3g, PCCT-6g, energy-integrating detector [EID]-6g, and PCCT-3g+water), the study evaluated effervescent powder dose and water-assisted preparation to determine effects on PCCT image quality and imaging performance. If effective, nurse-led standardized preparation could improve PCCT gas-VRT gastric visualization while optimizing effervescent dose and workflow feasibility.

Xiong PJ, Liu L, Jiang KX et al. · Academic radiology · (2026) · View on PubMed ↗

---

Dual-Energy CT (DECT) Pulmonary Angiography for Pulmonary Embolism

Dual-energy computed tomography pulmonary angiography for pulmonary embolism: a three-tier evidence framework to guide individualized low-iodine scanning.

This narrative review studied evidence supporting dual-energy CT pulmonary angiography (DECT CTPA) for pulmonary embolism (PE) with the goal of guiding individualized low-iodine scanning. Synthesizing 28 eligible studies (from January 2016 to June 2026) across image quality, diagnostic performance, and clinical outcomes, it proposed a three-tier evidence framework to standardize how low-iodine protocols should be implemented. The significance is that the framework can help clinicians choose low-iodine DECT CTPA strategies more safely and consistently while maintaining diagnostic reliability for PE.

Jiang Q, Qian L · Diagnostic and interventional radiology (Ankara, Turkey) · (2026) · View on PubMed ↗ · Free PDF ↗

---

Photon-Counting CT (PCCT) for Carotid Body Detection & Characterization

Carotid Body Detection Rate and Size on Photon-Counting Versus Energy-Integrating Detector CT.

This retrospective study compared carotid body (CB) detection rate and size on photon-counting CT (PCCT) versus energy-integrating detector CT (EIDCT) in 48 adults undergoing head-and-neck CTA. Using mixed-effects models across arterial and venous phases and laterality, it evaluated how modality, phase, and side influenced CB detectability and measured size. The findings are clinically significant because they inform which CT detector technology and contrast timing best support reliable CB assessment for potential future functional or disease-related applications.

Unger RH, Arizono E, Buch K et al. · AJNR. American journal of neuroradiology · (2026) · View on PubMed ↗

---

PCCT Biomarkers for Cancer Response Prediction (Rectal Adenocarcinoma)

Photon-counting computed tomography and magnetic resonance imaging in rectal cancer: reassessment of normalized iodine concentration and apparent diffusion coefficient in an expanded cohort.

This single-center retrospective study evaluated whether pretreatment photon-counting CT (PCCT)-derived normalized iodine concentration (NIC) in 63 patients with rectal adenocarcinoma aligns with MRI-derived apparent diffusion coefficient (ADC) as a within-cohort reference for neoadjuvant treatment response. Patients with Dworak tumor regression grades 0–1 were classified as poor responders and grades 2–4 as moderate/good responders, and the study reassessed PCCT NIC in relation to MRI ADC to better characterize response prediction. The significance is that PCCT iodine metrics—benchmarked against MRI diffusion—may improve noninvasive prediction of histopathologic response to neoadjuvant therapy in rectal cancer.

Saeed S, Shahzadi I, Niehoff JH et al. · Abdominal radiology (New York) · (2026) · View on PubMed ↗ · Free PDF ↗

---

Imaging Biomarkers & Standardization in Chronic Subdural Hematoma

ASFNR Clinical State of Practice Statement on Imaging of Chronic Subdural Hematoma.

This American Society of Functional Neuroradiology (ASFNR) clinical state-of-practice statement studied current imaging approaches for chronic subdural hematoma (cSDH), focusing on how imaging phenotypes may relate to neomembrane activity, recurrence risk, and patient selection for middle meningeal artery embolization (MMAE). It emphasizes that hematoma internal “imaging phenotype” has not yet been standardized or validated for incorporation into randomized trials or treatment-selection algorithms. The statement’s significance is to drive harmonized definitions and reporting of cSDH imaging biomarkers to better support evidence-based MMAE decision-making.

Ahmed S, Essibayi MA, Kakadiya J et al. · AJNR. American journal of neuroradiology · (2026) · View on PubMed ↗

---

---

Generated automatically on October 23, 2026. Covers PubMed articles published October 16, 2026 – October 23, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.